About Us:
We are an interdisciplinary group of researchers interested in engineering molecules and molecular scale interactions toward developing solutions for common problems. Our work is rooted in supramolecular design principles, and employs these tools toward problems that arise in healthcare, specifically toward the generation of improved therapeutics. As such, we build platforms based on predictable, tunable, modular, and high-affinity supramolecular interactions that offer unrivaled control over emergent properties. This affords problem-specific tailoring of materials, devices, or constructs to address the task at hand with enabling technologies. The interdisciplinary nature of this work necessitates a highly collaborative culture, and we actively seek partners from throughout the University of Notre Dame as well as the regional and global academic community. In addition, we are always open to partnering with industry leaders in order to help advance our ideas to market.
Recent Tweets:
-
After a big team effort over the last week, we’re now settled into the new space! https://t.co/tYJWHQ5QjO https://t.co/W6n7pH2n9m
-
Thank you, Prof Peppas! https://t.co/Xqku4PeMVQ
-
Big congrats to both Dr. Alderfer and her advisor! A special moment for the @DHPGroup! https://t.co/jg8ecz3XTD
-
After over a year of planning, the @WebberLab is on the move! Thanks to @UNDResearch and @NDCBE for supporting our… https://t.co/jIYiMJyP12
-
Big news for @WebberLab today with Four(!) GRFPs awarded. Current grad students Emily DeWolf & Connor Schmidt and c… https://t.co/BwGEpffhuu